The association of HLA-DQB1*0602 but not HLA-DRB1*15 with obstructive sleep apnea. 2017

Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
Department of Internal Medicine, Jordan University of Science and Technology. smomani@hotmail.com.

Obstructive sleep apnea (OSA) is a sleep breathing disorder with unclear multifactorial pathogenesis. This study aimed to investigate the association between OSA and two human leukocyte antigens (HLA) alleles; DQB1*0602 and DRB1*15. Forty patients with OSA and 40 control subjects were enrolled in the study. OSA diagnosis was made utilizing the Apnea-Hypopnea Index (AHI)≥5 in overnight polysomnography (PSG). AHI was also used to determine OSA severity. Controls were randomly selected from healthy volunteers who had a low risk for OSA, utilizing the Berlin Questionnaire. Polymerase chain reaction (PCR) using Sequence Specific Primers (PCR-SSPs) was used to determine the association between HLA (HLA-DQB1*0602 and HLA-DRB1*15) and OSA, then statistical analyses of the results were performed. HLA-DQB1*0602 allele was found in 85% of all OSA patients and 50% of controls (P< 0.001). In patients with severe OSA, HLA-DQB1*0602 was present in the 92.9% compared with 66.7% in non-severe OSA (P=0.05). HLA-DRB1*15 allele was found in 15% of OSA patients and 20% of controls, with no difference between the two groups (P=0.556). No statistical difference was found in HLA-DRB1*15 between severe and non-severe OSA (P=0.499). After adjusting for gender, HLA-DQB1*0602 allele was associated with increased odds of OSA (OR = 6.17, 95% CI 1.87-20.3, p = 0.003), but HLA-DRB1*15 allele was not associated with OSA (OR 0.45, 95% CI 0.12-1.73, p = 0.242). The presence of HLA-DQB1*0602 allele, but not HLA-DRB1*15 allele, was significantly associated with OSA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
September 2009, Arquivos de neuro-psiquiatria,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
September 2009, Journal of immunology (Baltimore, Md. : 1950),
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
July 2005, Human immunology,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
January 2021, Iranian journal of child neurology,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
April 2002, Japanese journal of cancer research : Gann,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
May 1999, Sleep,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
January 2005, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
October 2017, Iranian journal of allergy, asthma, and immunology,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
June 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG,
Suleiman M Momany, and Thamer A Al-Qatarneh, and Yousef S Khader, and Nizar M Abu-Harfeil, and Ammar K Daoud, and Amjad A Mahasneh
December 2005, Diabetologia,
Copied contents to your clipboard!